OraSure Technologies Unveils Innovative Blood Collection Device
OraSure Technologies Launches HEMAcollect™PROTEIN
In a significant move for researchers in the field of proteomics, OraSure Technologies, Inc., known colloquially as OTI (NASDAQ: OSUR), has introduced its latest product, HEMAcollect™PROTEIN. This innovative blood collection tube is designed to meet the diverse needs of proteomic research, specifically targeting the efficient preservation of plasma proteins.
Design and Functionality of HEMAcollect™PROTEIN
The HEMAcollect™PROTEIN product stands out in the market as it features a proprietary stabilizing liquid aimed at providing optimal conditions for plasma protein preservation. This cutting-edge design allows blood samples to be stored and transported at ambient temperatures for up to seven days. With this technology, proteomic researchers can expect enhanced operational efficiency, ensuring that the integrity of the samples remains intact.
"Our new blood collection tube represents a substantial leap forward in the realm of sample collection for proteomics," remarked Carrie Eglinton Manner, President and CEO of OTI. She emphasized how this product not only enhances the reliability of sample integrity but also significantly improves preanalytical workflows, which are crucial for obtaining accurate research results.
Benefits of the HEMAcollect™PROTEIN BCT
The HEMAcollect™PROTEIN BCT incorporates ProteoPrecision™ technology, which effectively reduces hemolysis and prevents platelet activation. This characteristic is vital for researchers as it ensures the collected samples are a true reflection of the patient's physiological state at the time of collection.
Importantly, the HEMAcollect™PROTEIN is compatible with a variety of advanced proteomic technologies, including mass spectrometry and high-throughput immunoassays. This compatibility allows for greater versatility in research applications across various medical fields including oncology, neurology, cardiology, and metabolic disorders, ultimately paving the way for groundbreaking discoveries.
About OraSure Technologies
OraSure Technologies, a pioneering entity in point-of-need and home diagnostic testing, strives to make healthcare more accessible and meaningful for individuals worldwide. The company is dedicated to enhancing the quality and accessibility of healthcare through its innovative products and sample management solutions.
Working alongside its subsidiaries, DNA Genotek and Sherlock Biosciences, OraSure has established a strong presence in the development and distribution of rapid diagnostic tests and sample stabilization devices. Their products cater to a wide customer base that includes clinical laboratories, hospitals, and research institutions.
About DNA Genotek
DNA Genotek stands as a vital subsidiary of OraSure Technologies, specializing in products that simplify sample collection while ensuring high-quality biological specimens. Their innovations empower clients to harness advanced genomic insights, thus facilitating significant advancements in health and science on a global scale.
Frequently Asked Questions
What is HEMAcollect™PROTEIN?
HEMAcollect™PROTEIN is an advanced blood collection tube designed to preserve plasma proteins for proteomic research, allowing for standard storage and transport conditions.
How does HEMAcollect™PROTEIN enhance research efficiency?
The product enables researchers to collect and manage blood samples more effectively while maintaining sample integrity, ultimately leading to more accurate research results.
What technologies are compatible with HEMAcollect™PROTEIN?
This blood collection tube is compatible with various proteomic technologies such as mass spectrometry and high-throughput immunoassays.
Who is behind the development of HEMAcollect™PROTEIN?
The product was developed by the subsidiary of OraSure Technologies, Inc., called DNA Genotek, which focuses on creating high-quality biological sample solutions for research.
How can I learn more about OraSure Technologies?
Visit OreSure’s official website for more comprehensive insights on their products and innovations in healthcare technology.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
